InMed Pharmaceuticals (INM) Non Operating Income (2020 - 2024)

InMed Pharmaceuticals has reported Non Operating Income for 3 years, with the latest figure at $528120.0 in Q2 2024.

• For the quarter ending Q2 2024, Non Operating Income rose 7.2% year-over-year to $528120.0; the trailing twelve-month figure through Jun 2024 stood at $1.3 million (up 97.37% YoY), and the FY2024 full-year result was $527901.0, up 7.2% from the prior year.
• Non Operating Income for Q2 2024 stood at $528120.0, up from $102987.0 in the prior quarter.
• The five-year high for Non Operating Income was $528120.0 in Q2 2024, with the low at -$360350.0 in Q4 2020.
• Historically, Non Operating Income has averaged $183779.2 across 3 years, with a median of $155497.0 in 2023.
• The largest YoY upside for Non Operating Income was 7.2% in 2024 against a maximum downside of 33.77% in 2024.
• InMed Pharmaceuticals' Non Operating Income stood at -$360350.0 in 2020, then soared by 236.71% to $492642.0 in 2023, then advanced by 7.2% to $528120.0 in 2024.
• The last three Non Operating Income figures came in at $528120.0 (Q2 2024), $102987.0 (Q1 2024), and $492642.0 (Q2 2023), per Business Quant data.